{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T18:22:42Z","timestamp":1773858162351,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Malnutrition is often overlooked as an extrapulmonary comorbidity in chronic obstructive pulmonary disease (COPD) and there is limited information regarding the nutritional status of younger individuals with mild-to-moderate disease in outpatient settings. We assessed energy and protein intakes in mild-to-moderate COPD patients compared to a group of healthy non-smoking individuals (HNS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      COPD patients and HNS were recruited; anthropometric measurements were assessed via BMI and bioelectrical impedance, while nutritional intake was assessed using a 7-day food diary and the EPIC-Norfolk Food Frequency Questionnaire (FFQ). Low fat-free mass index (FFMI) was defined as (a)\u2009&lt;\u200915\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      for females and\u2009&lt;\u200917\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      for males (Schols in Eur Respir J 44:1504\u20131520, 2014) or (b) adjusted for age, sex and BMI (Wei et al. in Front Endocrinol 14:1185221, 2023).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      21 COPD participants and 15 HNS were recruited with a median age of 58.0 and 57.0, respectively [IQR: 55.0\u201363.0 and 50.0\u201360.0]. A significantly greater proportion of individuals with COPD had a low FFMI when using age-sex-BMI adjusted criteria (23.8 vs. 0.0%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04). Using the estimated requirement threshold of 75%, more COPD patients did not meet nutritional protein requirements HNS (35% vs. 0%, respectively,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest a potential opportunity for dietary intervention in younger individuals to prevent future sequalae of malnutrition in COPD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00408-026-00876-0","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:30:35Z","timestamp":1773833435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Energy and Protein Intake in Mild-Moderate COPD Patients"],"prefix":"10.1007","volume":"204","author":[{"given":"R\u00f3is\u00edn","family":"Cullen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirtana Jagadeesh","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dave","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2690-5364","authenticated-orcid":false,"given":"Augusta","family":"Beech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avni","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"876_CR1","unstructured":"GOLD (2025) Global initiative for chronic obstructive lung disease: 2025 Report"},{"issue":"6","key":"876_CR2","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1183\/09031936.00070914","volume":"44","author":"AM Schols","year":"2014","unstructured":"Schols AM et al (2014) Nutritional assessment and therapy in COPD: a European Respiratory Society statement. Eur Respir J 44(6):1504\u20131520","journal-title":"Eur Respir J"},{"key":"876_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.850964","volume":"13","author":"K Ma","year":"2022","unstructured":"Ma K et al (2022) Pathogenesis of sarcopenia in chronic obstructive pulmonary disease. Front Physiol 13:850964","journal-title":"Front Physiol"},{"issue":"1","key":"876_CR4","first-page":"79","volume":"173","author":"J Vestbo","year":"2006","unstructured":"Vestbo J et al (2006) Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 173(1):79\u201383","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"876_CR5","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.clnu.2023.04.005","volume":"42","author":"M Deng","year":"2023","unstructured":"Deng M et al (2023) Global prevalence of malnutrition in patients with chronic obstructive pulmonary disease: systemic review and meta-analysis. Clin Nutr 42(6):848\u2013858","journal-title":"Clin Nutr"},{"key":"876_CR6","unstructured":"Day N et al (1999) EPIC-Norfolk: study design and characteristics of the cohort European Prospective Investigation of Cancer. Br J Cancer 80 Suppl 1: 95\u2013103"},{"issue":"3","key":"876_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004503","volume":"4","author":"AA Mulligan","year":"2014","unstructured":"Mulligan AA et al (2014) A new tool for converting food frequency questionnaire data into nutrient and food group values: FETA research methods and availability. BMJ Open 4(3):e004503","journal-title":"BMJ Open"},{"key":"876_CR8","unstructured":"Nutritics. Nutritics (Version 6). [Computer programme] 2024; 6:[Available from: https:\/\/www.nutritics.com\/en\/."},{"key":"876_CR9","unstructured":"PENG, A Pocket Guide to Clinical Nutrition Fifth ed. 2018, United Kingdom: British Dietetic Association"},{"key":"876_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1054\/clnu.2001.0417","volume":"20","author":"J Kondrup","year":"2001","unstructured":"Kondrup J (2001) Can food intake in hospital be improved. Clin Nutr CLIN NUTR 20:153\u2013160","journal-title":"Clin Nutr CLIN NUTR"},{"key":"876_CR11","doi-asserted-by":"crossref","unstructured":"Franssen, F.M., et al., New reference values for body composition by bioelectrical impedance analysis in the general population: results from the UK Biobank. J Am Med Dir Assoc, 15(6): 4481\u20136","DOI":"10.1016\/j.jamda.2014.03.012"},{"issue":"6","key":"876_CR12","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3945\/ajcn.111.023911","volume":"94","author":"B van den Borst","year":"2011","unstructured":"van den Borst B et al (2011) Low-grade adipose tissue inflammation in patients with mild-to-moderate chronic obstructive pulmonary disease. Am J Clin Nutr 94(6):1504\u20131512","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"876_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jcsm.12783","volume":"13","author":"F Petermann-Rocha","year":"2022","unstructured":"Petermann-Rocha F et al (2022) Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle 13(1):86\u201399","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"876_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1185221","volume":"14","author":"S Wei","year":"2023","unstructured":"Wei S et al (2023) Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management. Front Endocrinol 14:1185221","journal-title":"Front Endocrinol"},{"issue":"6","key":"876_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/BOR.0b013e328358d59b","volume":"24","author":"JD Walston","year":"2012","unstructured":"Walston JD (2012) Sarcopenia in older adults. Curr Opin Rheumatol 24(6):623\u2013627","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"876_CR16","doi-asserted-by":"publisher","first-page":"B267","DOI":"10.1093\/gerona\/52A.5.B267","volume":"52","author":"EJ Metter","year":"1997","unstructured":"Metter EJ et al (1997) Age-associated loss of power and strength in the upper extremities in women and men. J Gerontol A Biol Sci Med Sci 52(5):B267\u2013B276","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"Suppl 2","key":"876_CR17","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1123\/jpah.8.s2.s161","volume":"8","author":"DX Marquez","year":"2011","unstructured":"Marquez DX et al (2011) Physical activity of urban community-dwelling older Latino adults. J Phys Act Health 8(Suppl 2):S161\u2013S170","journal-title":"J Phys Act Health"},{"issue":"2","key":"876_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/1479972317736294","volume":"15","author":"BD James","year":"2018","unstructured":"James BD et al (2018) Obesity and metabolic syndrome in COPD: Is exercise the answer? Chron Respir Dis 15(2):173\u2013181","journal-title":"Chron Respir Dis"},{"issue":"2","key":"876_CR19","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1513\/AnnalsATS.201711-901ED","volume":"15","author":"AS Iyer","year":"2018","unstructured":"Iyer AS, Dransfield MT (2018) The \u201cObesity Paradox\u201d in chronic obstructive pulmonary disease: Can it be resolved? Ann Am Thorac Soc 15(2):158\u2013159","journal-title":"Ann Am Thorac Soc"},{"key":"876_CR20","doi-asserted-by":"publisher","DOI":"10.2174\/0118743064322829240801094830","volume":"18","author":"M El Labban","year":"2024","unstructured":"El Labban M et al (2024) Malnutrition and obesity in patients with COPD exacerbation, insights from the National Inpatient Sample. Open Respir Med J 18:e18743064322829","journal-title":"Open Respir Med J"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00876-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-026-00876-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00876-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:30:41Z","timestamp":1773833441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-026-00876-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["876"],"URL":"https:\/\/doi.org\/10.1007\/s00408-026-00876-0","relation":{},"ISSN":["1432-1750"],"issn-type":[{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RC, KN, AB and AV have no COI. DS has received personal fees from Adovate, Aerogen, Almirall, Apogee, Arrowhead, AstraZeneca, Bial, Boehringer Ingelheim, Chiesi, Cipla, CONNECT Biopharm, Covis, CSL Behring, DevPro Biopharma LCC, Elpen, Empirico, EpiEndo, Genentech, Generate Biomedicines, GlaxoSmithKline, Glenmark, Kamada, Kinaset Therapeutics, Kymera, Menarini, MicroA, OM Pharma, Orion, Pieris Pharmaceuticals, Pulmatrix, Revolo, Roivant Sciences, Sanofi, Synairgen, Tetherex, Teva, Theravance Biopharma, Upstream and Verona Pharma.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"14"}}